Khiron Life Sciences Corp.: Invitation to the Q1 Virtual Investor Summit
Khiron Life Sciences Corp.: Invitation to the Q1 Virtual Investor Summit
For further information:Toronto, Ontario--(Newsfile Corp. - February 24, 2022) - Khiron Life Sciences Corp. (TSXV: KHRN.V) today announced that Alvaro Torres will be attending the Q1 Virtual Investor Summit. Mr. Torres is the founder, CEO and Director of Khiron. He has almost two decades of experience in the Latin American market, including infrastructure projects and project finance, management strategy, team development, and mergers and acquisitions. Mr. Torres was previously head of business development for SNC-Lavalin, Colombia, and was instrumental in growing the company from two people to more than 2,000 people in Colombia over the course of three years. Mr. Torres has overseen the development of projects totaling over $1 billion in capital expenditure, including the development and construction of Colombia's tallest skyscraper. Mr. Torres holds a Bachelor of Engineering and a Master of Engineering from Rensselaer Polytechnic Institute and an MBA from Georgetown University.
安大略省多倫多-(Newsfile Corp.-2022年2月24日)凱龍生命科學公司(Khron Life Science Corp.)多倫多證券交易所股票代碼：KHRN.V)今天宣佈，Alvaro Torres將出席第一季度虛擬投資者峯會。託雷斯是啟龍科技的創始人、首席執行長兼董事(Sequoia Capital)。他在拉丁美洲市場擁有近20年的經驗，包括基礎設施項目和項目融資、管理戰略、團隊發展和併購。託雷斯先生之前是哥倫比亞SNC-Lavalin公司的業務發展主管，在三年的時間裏，他幫助公司在哥倫比亞從兩個人發展到2000多人。託雷斯監督了總計超過10億美元資本支出的項目的開發，包括開發和建設哥倫比亞最高的摩天大樓。託雷斯先生擁有倫斯勒理工學院的工程學士和工程碩士學位，以及喬治敦大學的工商管理碩士學位。
| Event: | Q1 Investor Summit | |
| Date: | March 8-9th, 2022 | |
| Presentation: | March 8th at 9:30AM ET | |
| Location: |
| 活動： | 第一季度投資者峯會 | |
| 日期： | 2022年3月8日至9日 | |
| 演示文稿： | 3月8日美國東部時間上午9：30 | |
| 位置： |
- 1x1s will be available for qualified investors
- The conference is completely complimentary to qualified investors. Please register at Complimentary Investor Registration
- 合格投資者可使用1x1
- 這次會議完全是對合格投資者的免費贈送。請於免費投資者登記處登記
About Khiron Life Sciences Corp.
關於Khron生命科學公司
Khiron is a leading global medical cannabis company with core operations in Latin America and Europe. Leveraging wholly-owned medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific expertise, product innovation, and focus on creating accessto drive prescriptions and brand loyalty with patients worldwide. The Company has a sales presence in Colombia, Peru, Germany, UK, and Brazil and is positioned to commence sales in Mexico. The Company is led by Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and diverse executive team and Board of Directors.
科龍公司是全球領先的醫用大麻公司，核心業務在拉丁美洲和歐洲。利用全資擁有的醫療保健診所和專有的遠程醫療平臺，Khron將以患者為中心的方法、醫生教育計劃、科學專長、產品創新結合在一起，專注於創建渠道，以提高全球患者的處方和品牌忠誠度。該公司在哥倫比亞、祕魯、德國、英國和巴西設有銷售機構，並準備在墨西哥開始銷售。該公司由聯合創始人兼首席執行官阿爾瓦羅·託雷斯(Alvaro Torres)領導，以及一支經驗豐富、多元化的管理團隊和董事會。
For further information:
有關更多信息，請訪問：
Khiron Life Sciences Corp.
Khiron Life Sciences Corp.
+1 647 556-5750
investors@khiron.ca
凱龍生命科學公司(Khron Life Science Corp.)
凱龍生命科學公司(Khron Life Science Corp.)
+1 647 556-5750
郵箱：Investors@khiron.ca
About the Investor Summit
關於投資者峯會
The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q1 Investor Summit will take place virtually, featuring 90+ companies and over 500 investors comprising institutional investors, family offices, and high net worth investors. Sectors Participating: Biotech, Communication Services, Consumer, Energy, Energy/Tech, Financial, Healthcare, Industrials, Materials, Real Estate, Technology, and Tech/Crypt. Contact: info@investorsummitgroup.com
投資者峯會(前身為MicroCap Conference)是一個獨家、獨立的會議，致力於將小盤股和微盤股公司與合格投資者聯繫起來。第一季度投資者峯會將虛擬舉行，有90多家公司和500多名投資者參加，其中包括機構投資者、家族理財室和高淨值投資者。參與行業：生物技術、通信服務、消費、能源、能源/技術、金融、醫療保健、工業、材料、房地產、技術和技術/加密。聯繫人：info@investorsummitgroup.com
譯文內容由第三人軟體翻譯。
